サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1370358

口蹄疫（FMD）ワクチン市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Foot and Mouth Disease (FMD) Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
口蹄疫（FMD）ワクチン市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要 2023-2028年

口蹄疫（FMD）ワクチンの世界市場規模は、2022年に19億7,860万米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて7.2%の成長率（CAGR）を示し、2028年までに30億7,070万米ドルに達すると予測しています。

口蹄疫（FMD）は、蹄を持つ動物に感染する越境伝染性ウイルスによって発生します。主に水牛、豚、羊、ヤギなどの家畜と、シカ、バイソン、ラクダ科の動物、カモシカなどの野生動物が罹患します。FMDウイルス（FMDV）には、免疫学的に異なる7つの血清型、すなわちO、A、C、SAT1、SAT2、SAT3、およびAsia 1があります。このウイルス性疾患は、唇や舌の水疱、発熱、唾液分泌過多、食欲不振、肉や乳の生産性低下など、動物に共通の症状を示します。FMDの感染に対しては、水酸化アルミニウム、サポニン、油剤をベースにしたいくつかのワクチンが使用されています。

FMDの高い流行と、畜産物の国際取引に対する社会経済的影響が、FMDワクチン市場を牽引しています。食肉加工産業の成長と乳製品の消費の増加も、FMDワクチンの必要性を煽っています。さらに、家畜から供給される高品質かつ無病の食肉に対する需要の高まりが、市場の成長をさらに後押ししています。これとは別に、牛の飼育に関する義務的な規範の実施が、FMDの発生を抑制するためのワクチンの大量購入につながっています。さらに、世界中の政府機関は、バイソンやカモシカといった絶滅の危機に瀕している野生動物種をFMDから保護するために、いくつかの啓発プログラムを導入しています。先進国市場と新興国市場の双方で、家畜人口の増加とともに世界化が進んでいることも、FMDワクチン市場を牽引しています。さらに、家畜に安全なヘルスケアを提供する動物病院の存在感が増していることも、市場成長に好影響を与えています。

本レポートで扱う主な質問

  • 口蹄疫（FMD）ワクチンの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の口蹄疫（FMD）ワクチン市場に与えた影響は？
  • 主要な地域市場は？
  • 動物タイプに基づく市場内訳は？
  • ワクチンタイプ別の市場内訳は？
  • 流通チャネル別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は？
  • 世界の口蹄疫（FMD）ワクチン市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 口蹄疫（FMD）ワクチンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：動物タイプ別

  • ウシ
    • 市場動向
    • 市場予測
  • ブタ
    • 市場動向
    • 市場予測
  • ヒツジとヤギ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：ワクチンタイプ別

  • 従来型ワクチン
    • 市場動向
    • 油性ワクチン
      • 市場動向
      • 市場予測
    • 水酸化アルミニウム/サポニンベースワクチン
      • 市場動向
      • 市場予測
    • 市場予測
  • 緊急用ワクチン
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 政府機関
    • 市場動向
    • 市場予測
  • ディストリビューター/薬局
    • 市場動向
    • 市場予測
  • 個人獣医
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • バングラデシュ
      • 市場動向
      • 市場予測
    • ベトナム
      • 市場動向
      • 市場予測
    • 韓国市場
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • アルゼンチン
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • ナイジェリア
      • 市場動向
      • 市場予測
    • エチオピア
      • 市場動向
      • 市場予測
    • イラン
      • 市場動向
      • 市場予測
    • アルジェリア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • トルコ
      • 市場動向
      • 市場予測
    • グルジア
      • 市場動向
      • 市場予測
    • アルメニア
      • 市場動向
      • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Paramount Agrovet Pvt. Ltd.
    • Bayer AG
    • Biogenesis Bago
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma Private Limited
    • China Animal Husbandry Group
    • FGBI"Federal Center for Animal Health"
    • Indian Immunologicals Ltd.
    • Limor de Colombia
    • Merck & Co. Inc
    • Vecol S.A.
    • Vetal Animal Health Products Inc.
図表

List of Figures

  • Figure 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Major Drivers and Challenges
  • Figure 2: Global: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Animal Type (in %), 2022
  • Figure 4: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Vaccine Type (in %), 2022
  • Figure 5: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: China: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Korea: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Korea: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Latin America: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Brazil: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Brazil: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Argentina: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Argentina: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Latin America: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Iran: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Iran: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Algeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Algeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Turkey: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Turkey: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Georgia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Georgia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Armenia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Armenia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Foot and Mouth Disease (FMD) Vaccine Industry: SWOT Analysis
  • Figure 75: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Value Chain Analysis
  • Figure 76: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Animal Type (in Million US$), 2023-2028
  • Table 3: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 4: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Competitive Structure
  • Table 7: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Players
目次
Product Code: SR112023A2871

Abstract

Market Overview 2023-2028:

The global foot and mouth disease (FMD) vaccine market size reached US$ 1,978.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,070.7 Million by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.

The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide, saponin, and oil formulations, are used against FMD contraction.

The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks. Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global foot and mouth disease (FMD) vaccine market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on animal type, vaccine type and distribution channel.

Breakup by Animal Type:

Cattle

Pig

Sheep and Goat

Others

Breakup by Vaccine Type:

Conventional Vaccines

Oil-Based Vaccines

Aluminum hydroxide/saponin-based Vaccines

Emergency Vaccines

Breakup by Distribution Channel:

Government Organizations

Distributors/Pharmacies

Private Vet

Others

Breakup by Region:

Asia Pacific

China

India

Bangladesh

Vietnam

Korea

Others

Latin America

Brazil

Argentina

Others

Middle East and Africa

Nigeria

Ethiopia

Iran

Algeria

Others

Europe

Turkey

Georgia

Armenia

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Center for Animal Health", Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc.

Key Questions Answered in This Report:

  • How has the global foot and mouth disease (FMD) vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global foot and mouth disease (FMD) vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global foot and mouth disease (FMD) vaccine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Foot and Mouth Disease (FMD) Vaccine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Cattle
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pig
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sheep and Goat
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Vaccine Type

  • 7.1 Conventional Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Oil-Based Vaccines
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
    • 7.1.3 Aluminum hydroxide/saponin-based Vaccines
      • 7.1.3.1 Market Trends
      • 7.1.3.2 Market Forecast
    • 7.1.4 Market Forecast
  • 7.2 Emergency Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Government Organizations
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Distributors/Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Private Vet
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 China
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 India
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Bangladesh
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Vietnam
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Korea
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Latin America
    • 9.2.1 Brazil
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Argentina
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Others
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
  • 9.3 Middle East and Africa
    • 9.3.1 Nigeria
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Ethiopia
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Iran
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Algeria
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Others
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
  • 9.4 Europe
    • 9.4.1 Turkey
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Georgia
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Armenia
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Paramount Agrovet Pvt. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogenesis Bago
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Brilliant Bio Pharma Private Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 China Animal Husbandry Group
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FGBI "Federal Center for Animal Health"
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Limor de Colombia
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Merck & Co. Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vecol S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vetal Animal Health Products Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio